The HEART's Leadership.

Dedicated men & Women united to defeat Amyloidosis

Pr. Thibaut Damy (MD, PhD)

FOUNDER & CEO

Pr. Damy is one of few worldwide experts on cardiac diseases. He implemented the first cardiac amyloidosis therapies, and has worked to increase the awareness of the public and medical professionals on the illness. He founded and leads the HEART’s foundation, which coordinates research and operations against Cardiac Amyloidosis at the National level.

Dr. Charles Taieb (MD, PhD)

Co-Founder & Executive Director P.R.O

Dr. Taieb has an extensive experience of 30 years working with Sanofi and other major stakeholders of the pharmaceutical industry. He is an expert in Patient Reported Outcomes in real life and monitors the impact of medical treatment and procedures on a large group of patients diagnosed with Amyloidosis.

Mounira Kharoubi

CO-FOUNDER & EXECUTIVE Director

Ms. Knaroubi has been working within the Amyloidosis CHU Mondor Network for many years. She has decades of experience organizing clinical trials and playing an essential role in cutting-edge research projects. She leads the coordination aspects between the HEART’s foundation and the current CHU Amyloidosis operations.

Sidney Silva

Project Manager

Mr. Silva has an extensive experience in legal and bioscience regulations. He drives the HEAR registry projet implementation among the different operational centers throughout France. Prior to working with HEART’s, he worked as a researcher for the first French CRO. 

Reach Out

To learn more about how our research is making a difference for those living with amyloidosis.

Healthcare European Amyloidosis Research Translation and strategy

Copyright © 2019 HEARTS, Tous droits réservés

+33 (0)1 49 81 22 53

Healthcare European Amyloidosis Research Translation and strategy
19, rue de Fontenay 94300 VINCENNES

Fermer le menu